FLNA功能缺失变异患者的肺动脉高压:法国PH网络队列研究
该研究报道了来自法国肺动脉高压网络的9例携带FLNA功能缺失变异且合并肺动脉高压的患者,女男比为8:1,诊断中位年龄36岁。右心导管证实为中重度毛细血管前性肺动脉高压,伴弥散功能显著下降及肺部影像学异质性改变。结论提示FLNA功能缺失变异患者可出现多机制参与的毛细血管前性肺动脉高压,且可能为首发表现。
要点
- FLNA功能缺失变异患者可发生中重度毛细血管前性肺动脉高压,女男比8:1。
- 肺动脉高压可为首发表现,伴肺部实质受累及肺外症状时应警惕FLNA变异。
- 随访中3例死亡,其中2例死于右心衰竭,未见主动脉破裂死亡。
核心结论
- 毛细血管前性肺动脉高压可能由多种机制导致,可并发于FLNA功能缺失变异患者病程中,并可能为首发症状。
- 肺动脉高压合并肺实质受累及肺外表现(癫痫、先天性心脏病、瓣膜及主动脉受累、血小板减少)时应促使进行FLNA基因筛查。
研究设计与样本
- 来自法国肺动脉高压网络的病例系列,报告携带FLNA功能缺失变异且合并肺动脉高压患者的临床、功能、血流动力学及影像学特征。
- 共识别9例患者,女男比为8:1。
主要发现
- 肺动脉高压诊断中位(范围)年龄为36(0-69)岁。
- 合并症包括癫痫(n=5)、室周结节性异位(PVNH,n=7)、瓣膜性心脏病(n=8)、先天性心脏病(n=4)、血小板减少(n=4)及关节过度松弛(n=4)。
- 右心导管证实为中重度毛细血管前性肺动脉高压,中位(范围)平均肺动脉压33(22-49)mmHg,肺血管阻力4.7(2.4-8.0)WU。
- 血红蛋白校正的一氧化碳弥散量中位(范围)显著下降至预计值的48%(22-64%),5例存在阻塞性通气功能障碍。
- 高分辨率CT显示肺实质异质性(n=8)、肺气肿(n=3)、外周透亮带(n=3)及主动脉扩张(n=4);1例病理显示小肺动脉显著重塑、间质水肿及肺泡形态不规则。
临床怎么用
- 对肺动脉高压合并肺实质受累及肺外表现(癫痫、先天性心脏病、瓣膜及主动脉受累、血小板减少)的患者,应考虑FLNA基因筛查。
- FLNA功能缺失变异患者出现肺动脉高压时,应评估右心功能及血流动力学,警惕右心衰竭死亡风险。
局限性
- 样本量小(9例),为病例系列描述性研究。
- 仅1例有病理学评估资料。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pulmonary hypertension (PH) is an unusual complication of X-linked disease caused by loss-of-function (LOF) variants in the filamin A (FLNA) gene. Patients with FLNA LOF may also present dysmorphic facial features, aortic dilation, thrombocytopenia and periventricular nodular heterotopia (PVNH). METHODS: We reported the clinical, functional, haemodynamic and radiological characteristics of patients with FLNA LOF variants and PH from the French PH Network. RESULTS: Nine patients were identified with a female:male ratio of 8:1. PH was diagnosed at a median (range) age of 36 (0-69) years. Associated conditions included epilepsy (n=5), PVNH (n=7), valvular heart disease (n=8), congenital heart diseases (n=4), thrombocytopenia (n=4) and hyperlaxity (n=4). Right heart catheterisation confirmed moderate-to-severe pre-capillary PH with a median (range) mean pulmonary arterial pressure of 33 (22-49) mmHg and pulmonary vascular resistance of 4.7 (2.4-8.0) WU. The median (range) diffusing capacity of the lung for carbon monoxide corrected for haemoglobin was markedly decreased (48% (22-64%) of predicted values) and five patients had obstructive ventilatory disorder. High-resolution computed tomography showed heterogeneous parenchyma (n=8), emphysema (n=3), presence of a peripheral hyperclear band (n=3) and aortic ectasia (n=4). Pathological assessment available in one patient revealed significant remodelling of small pulmonary arteries, interstitial oedema and irregular alveoli shapes. During follow-up, three patients died, including two from right heart failure. No patient died from aortic rupture. CONCLUSIONS: Pre-capillary PH, likely due to multiple mechanisms, may complicate the course of patients with FLNA LOF variants and may be the presenting symptom leading to diagnosis. The combination of PH with parenchymal involvement and extrapulmonary symptoms (epilepsy, congenital heart diseases, valvular and aortic involvement, and thrombocytopenia) should prompt genetic screening for FLNA.
引用
- Stourm L, Grynblat J, Savale L, et al. Pulmonary hypertension in patients carrying FLNA loss-of-function variants. Eur Respir J. 2025. PMID: 39510553. doi:10.1183/13993003.01132-2024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。